IL92120A - Cyclosporin opthalmic compositions - Google Patents

Cyclosporin opthalmic compositions

Info

Publication number
IL92120A
IL92120A IL9212089A IL9212089A IL92120A IL 92120 A IL92120 A IL 92120A IL 9212089 A IL9212089 A IL 9212089A IL 9212089 A IL9212089 A IL 9212089A IL 92120 A IL92120 A IL 92120A
Authority
IL
Israel
Prior art keywords
composition according
component
composition
present
cyclosporin
Prior art date
Application number
IL9212089A
Other languages
English (en)
Other versions
IL92120A0 (en
Original Assignee
Sandoz A G Basle Switzerland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz A G Basle Switzerland filed Critical Sandoz A G Basle Switzerland
Publication of IL92120A0 publication Critical patent/IL92120A0/xx
Publication of IL92120A publication Critical patent/IL92120A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL9212089A 1988-10-26 1989-10-25 Cyclosporin opthalmic compositions IL92120A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26

Publications (2)

Publication Number Publication Date
IL92120A0 IL92120A0 (en) 1990-07-12
IL92120A true IL92120A (en) 1994-02-27

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9212089A IL92120A (en) 1988-10-26 1989-10-25 Cyclosporin opthalmic compositions

Country Status (23)

Country Link
JP (1) JPH02164830A (cg-RX-API-DMAC10.html)
KR (1) KR900005973A (cg-RX-API-DMAC10.html)
AU (1) AU626928B2 (cg-RX-API-DMAC10.html)
BE (1) BE1003578A4 (cg-RX-API-DMAC10.html)
CA (1) CA2001502A1 (cg-RX-API-DMAC10.html)
CH (1) CH679210A5 (cg-RX-API-DMAC10.html)
DE (1) DE3935517A1 (cg-RX-API-DMAC10.html)
DK (1) DK531289A (cg-RX-API-DMAC10.html)
ES (1) ES2020032A6 (cg-RX-API-DMAC10.html)
FI (1) FI895064A7 (cg-RX-API-DMAC10.html)
FR (1) FR2638089A1 (cg-RX-API-DMAC10.html)
GB (1) GB2224205B (cg-RX-API-DMAC10.html)
GR (1) GR1000611B (cg-RX-API-DMAC10.html)
HU (1) HU203046B (cg-RX-API-DMAC10.html)
IL (1) IL92120A (cg-RX-API-DMAC10.html)
LU (1) LU87613A1 (cg-RX-API-DMAC10.html)
MY (1) MY106271A (cg-RX-API-DMAC10.html)
NL (1) NL8902657A (cg-RX-API-DMAC10.html)
NO (1) NO894266L (cg-RX-API-DMAC10.html)
NZ (1) NZ231131A (cg-RX-API-DMAC10.html)
PT (1) PT92120B (cg-RX-API-DMAC10.html)
SE (1) SE8903583L (cg-RX-API-DMAC10.html)
ZA (1) ZA898140B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
PT988046E (pt) 1997-01-30 2004-12-31 Novartis Ag Composicoes farmaceuticas sem oleo contendo ciclosporina a
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
MX2010004366A (es) * 2007-11-05 2010-05-05 Bausch & Lomb Materiales inmiscibles en agua como vehiculos para suministro de farmacos.
NO2437762T3 (cg-RX-API-DMAC10.html) * 2009-06-05 2018-01-06
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
MX381639B (es) 2016-12-23 2025-03-13 Novaliq Gmbh Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
CN114449999A (zh) 2019-09-06 2022-05-06 诺瓦利克有限责任公司 用于治疗葡萄膜炎的眼用组合物
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
AU626928B2 (en) 1992-08-13
SE8903583L (sv) 1990-04-27
NZ231131A (en) 1992-06-25
HUT52394A (en) 1990-07-28
GR1000611B (el) 1992-08-31
BE1003578A4 (fr) 1992-04-28
KR900005973A (ko) 1990-05-07
NO894266D0 (no) 1989-10-26
NO894266L (no) 1990-04-27
PT92120A (pt) 1990-04-30
SE8903583D0 (sv) 1989-10-26
HU203046B (en) 1991-05-28
DK531289A (da) 1990-04-27
DE3935517A1 (de) 1990-05-03
PT92120B (pt) 1995-06-30
ZA898140B (en) 1991-06-26
IL92120A0 (en) 1990-07-12
LU87613A1 (fr) 1991-05-07
HU895444D0 (en) 1990-01-28
GB2224205A (en) 1990-05-02
FI895064A0 (fi) 1989-10-25
JPH02164830A (ja) 1990-06-25
GB2224205B (en) 1992-04-15
MY106271A (en) 1995-04-29
NL8902657A (nl) 1990-05-16
GR890100690A (en) 1990-11-29
AU4371589A (en) 1990-05-03
FR2638089A1 (fr) 1990-04-27
ES2020032A6 (es) 1991-07-16
CH679210A5 (cg-RX-API-DMAC10.html) 1992-01-15
DK531289D0 (da) 1989-10-25
GB8924040D0 (en) 1989-12-13
CA2001502A1 (en) 1990-04-26
FI895064A7 (fi) 1990-04-27

Similar Documents

Publication Publication Date Title
AU626928B2 (en) Cyclosporin opthalmic compositions
IT8948485A1 (it) Composizioni oftalmiche a base di una ciclosporina (caso 600-7089)
EP0642332B1 (en) Ophthalmic compositions containing a cyclosporin
Constad et al. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma
US5294604A (en) Method of treating ocular diseases by periocular administration of cyclosporine A or G
US6579901B2 (en) Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
Flach et al. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier
EP4025235B1 (en) Ophthalmic composition for the treatment of uveitis
US11654140B2 (en) Treatment of ocular inflammatory diseases using laquinimod
US20210106558A1 (en) Pharmaceutical compositions comprising nebivolol
CZ423797A3 (cs) Topické přípravky s imunosupresivy
BRPI0708483A2 (pt) formulações farmacêuticas de latrunculina
van Sorge et al. Flurbiprofen, S (+), eyedrops: formulation, enantiomeric assay, shelflife and pharmacology
Grehn et al. Thymoxamine: a miotic for intraocular use
Fallor et al. Ocular toxicity of experimental intravitreal vitamin E

Legal Events

Date Code Title Description
RH Patent void